M Ledermann

1.1k total citations
23 papers, 862 citations indexed

About

M Ledermann is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, M Ledermann has authored 23 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in M Ledermann's work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). M Ledermann is often cited by papers focused on Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). M Ledermann collaborates with scholars based in Switzerland, United States and Germany. M Ledermann's co-authors include Vreni Schneider, Markus Neef, Jean‐François Dufour, Juerg Reichen, Felix Stickel, Eleonora Patsenker, Hans Sägesser, C. Redaelli, David Semela and Jeffrey R. Idle and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M Ledermann

23 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ledermann Switzerland 13 387 314 303 195 71 23 862
C N Ou United States 10 345 0.9× 409 1.3× 162 0.5× 348 1.8× 58 0.8× 16 1.2k
Jürgen Kropf Germany 11 227 0.6× 203 0.6× 301 1.0× 200 1.0× 73 1.0× 13 749
Abdul M. Oseini United States 14 251 0.6× 290 0.9× 577 1.9× 206 1.1× 72 1.0× 23 937
Itsuro Ogata Japan 22 668 1.7× 305 1.0× 374 1.2× 407 2.1× 110 1.5× 43 1.2k
Rie Irie Japan 14 285 0.7× 186 0.6× 390 1.3× 229 1.2× 70 1.0× 56 827
Hans Nordlinder Sweden 18 320 0.8× 394 1.3× 405 1.3× 137 0.7× 190 2.7× 40 1.3k
Berna Savaş Türkiye 18 451 1.2× 197 0.6× 737 2.4× 308 1.6× 127 1.8× 74 1.3k
Keizo Kagawa Japan 20 331 0.9× 300 1.0× 360 1.2× 189 1.0× 232 3.3× 70 1.1k
Tetsuya Yasunaka Japan 20 584 1.5× 153 0.5× 622 2.1× 262 1.3× 82 1.2× 72 1.1k
Shusen Zheng China 16 195 0.5× 197 0.6× 204 0.7× 264 1.4× 140 2.0× 62 852

Countries citing papers authored by M Ledermann

Since Specialization
Citations

This map shows the geographic impact of M Ledermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ledermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ledermann more than expected).

Fields of papers citing papers by M Ledermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ledermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ledermann. The network helps show where M Ledermann may publish in the future.

Co-authorship network of co-authors of M Ledermann

This figure shows the co-authorship network connecting the top 25 collaborators of M Ledermann. A scholar is included among the top collaborators of M Ledermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ledermann. M Ledermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mertens, Joachim C., Bettina Saar, Joachim Kettenbach, et al.. (2011). 211 EFFECTS OF RADIOFREQUENCY ABLATION (RFA) IN COMBINATION WITH SORAFENIB IN A 2-TUMOR RAT MODEL OF HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 54. S89–S89. 1 indexed citations
2.
Lanz, Christian, M Ledermann, Josef Slavík, & Jeffrey R. Idle. (2010). The production and composition of rat sebum is unaffected by 3 Gy gamma radiation. International Journal of Radiation Biology. 87(4). 360–371. 13 indexed citations
3.
Patsenker, Eleonora, Vreni Schneider, M Ledermann, et al.. (2010). Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. Journal of Hepatology. 55(2). 388–398. 105 indexed citations
4.
Romanque, Pamela, et al.. (2010). 42 SORAFENIB AND LIVER REGENERATION. Journal of Hepatology. 52. S18–S19. 1 indexed citations
5.
Patsenker, Eleonora, Yury Popov, Felix Stickel, et al.. (2009). Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #. Hepatology. 50(5). 1501–1511. 131 indexed citations
6.
7.
Piguet, Anne‐Christine, et al.. (2009). 536 THE COMBINATION EVEROLIMUS (RAD001) PLUS SORAFENIB IS SUPERIOR TO SORAFENIB MONOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 50. S199–S199. 1 indexed citations
8.
Chtioui, Haïthem, David Semela, M Ledermann, Arthur Zimmermann, & Jean‐François Dufour. (2007). Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis. Liver International. 27(6). 764–771. 46 indexed citations
9.
Hammer, Caroline, et al.. (2007). Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2. Journal of drug targeting. 15(9). 623–631. 26 indexed citations
10.
11.
Biecker, Erwin, Andrea De Gottardi, Markus Neef, et al.. (2005). Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms. Journal of Pharmacology and Experimental Therapeutics. 313(3). 952–961. 69 indexed citations
12.
Neef, Markus, M Ledermann, Vreni Schneider, et al.. (2005). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of Hepatology. 44(1). 167–175. 73 indexed citations
13.
Koshy, Abraham, Andrea De Gottardi, M Ledermann, et al.. (2005). Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice. Liver International. 25(5). 1044–1052. 13 indexed citations
14.
Redaelli, C., David Semela, Francine E. Carrick, et al.. (2003). Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. Journal of Hepatology. 40(2). 305–312. 52 indexed citations
15.
Redaelli, C., Yinghua Tian, Thomas Schaffner, et al.. (2002). Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology. 35(5). 1082–1092. 80 indexed citations
16.
Semela, David, M Ledermann, Arthur Zimmermann, & Jean‐François Dufour. (2002). Activity of CYP2E1 measured by the chlorzoxazone test in patients with non-alcoholic steatohepatitis and activation of stellate cells. Journal of Hepatology. 36. 146–146. 2 indexed citations
17.
Krähenbühl, L., et al.. (2000). Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis. Journal of Hepatology. 33(2). 216–223. 24 indexed citations
18.
Mordasini, R, et al.. (1984). [Traumatic rupture of the Achilles tendon and hyperlipidemia].. PubMed. 87(5). 226–9. 8 indexed citations
19.
Kocher, Hemant M., et al.. (1980). [Results following plastic replacement of the distal fibular ligaments with autologous corium].. PubMed. 47(1-2). 133–6. 1 indexed citations
20.
Ledermann, M & J. Cordey. (1979). [Registration of fibular movements in vivo in relation to the tibia at the level of the ankle joint].. PubMed. 46(1-2). 7–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C N Ou Breakdown of academic impact, for papers by Jürgen Kropf Breakdown of academic impact, for papers by Abdul M. Oseini Breakdown of academic impact, for papers by Itsuro Ogata Breakdown of academic impact, for papers by Rie Irie Breakdown of academic impact, for papers by Hans Nordlinder Breakdown of academic impact, for papers by Berna Savaş Breakdown of academic impact, for papers by Keizo Kagawa Breakdown of academic impact, for papers by Tetsuya Yasunaka Breakdown of academic impact, for papers by Shusen Zheng
Rankless by CCL
2026